Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | PNP | P00491 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29752538 | 1.00 | KDM4E (0.60) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL3685090 | 1.00 | KDM4E (0.60) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL3370869 | 1.00 | KDM4E (0.60) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL26661419 | 1.00 | KDM4E (0.60) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL6330240 | 0.95 | KDM4E (0.54) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| Formaldehyde SCHEMBL21638814 | 0.94 | KDM4E (0.54) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| Meglumine SCHEMBL29757165 | 0.92 | KDM4E (0.76) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL9444652 | 0.85 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL29344590 | 0.85 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL5551085 | 0.85 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3144 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095045-A | Etching composition | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4245293-B1 | USE OF SUGAR AMINES AS COMPLEXING AGENTS | CLARIANT INT LTD (CH) | 2025-08-06 | — | — | EP | claimed |
| WO-2025106343-A1 | ETCHING METHODS | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2025-05-22 | — | — | WO | claimed |
| US-20250157825-A1 | ETCHING METHODS | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2025-05-15 | — | — | US | claimed |
| WO-2025096565-A1 | ETCHING COMPOSITIONS | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250136865-A1 | Etching Compositions | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. | 2025-05-01 | — | — | US | claimed |
| CN-119896673-A | Application of GLP-1R agonist and metformin in preparation of drugs for treating diabetes and complications thereof | 深圳信立泰药业股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| EP-3972698-B1 | ORAL COMPOSITIONS AND METHODS OF USE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-02-12 | — | — | EP | claimed |
| WO-2024264013-A1 | BIOAVAILABILITY ENHANCING IONIC LIQUID FORMULATIONS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-12-26 | — | — | WO | claimed |
| WO-1996013564-A1 | NON-AQUEOUS COMPOSITIONS COMPRISING POLYHYDROXY FATTY ACID AMIDES | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-09 | — | — | WO | claimed |
| EP-0486046-B1 | S(+)-Phenyl-alkanoic acids and aminosugar containing complexes | PUETTER MEDICE CHEM PHARM (DE) | 1996-05-01 | — | — | EP | claimed |
| EP-0550632-B1 | PHASE TRANSFER ASSISTED PROCESS FOR GLUCAMIDE DETERGENTS | PROCTER & GAMBLE (US) | 1994-11-30 | — | — | EP | claimed |
| US-5338487-A | Reacting fatty acid ester and N-alkylglucamine in the presence of catalyst | THE PROCTER & GAMBLE COMPANY (US) | 1994-08-16 | — | — | US | claimed |
| US-5338486-A | Reacting fatty acid ester and N-alkyl glucamine in the presence of fatty alcohol ethoxylate and catalyst | THE PROCTER & GAMBLE COMPANY (US) | 1994-08-16 | — | — | US | claimed |
| EP-0550651-A1 | IMPROVED CATALYZED PROCESS FOR GLUCAMIDE DETERGENTS. | PROCTER & GAMBLE (US) | 1993-07-14 | — | — | EP | claimed |
| EP-0550632-A1 | PHASE TRANSFER ASSISTED PROCESS FOR GLUCAMIDE DETERGENTS. | PROCTER & GAMBLE (US) | 1993-07-14 | — | — | EP | claimed |
| WO-1992006072-A1 | IMPROVED CATALYZED PROCESS FOR GLUCAMIDE DETERGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-16 | — | — | WO | claimed |
| WO-1992006071-A1 | PHASE TRANSFER ASSISTED PROCESS FOR GLUCAMIDE DETERGENTS | THE PROCTER & GAMBLE COMPANY (US) | 1992-04-16 | — | — | WO | claimed |
| US-3937733-A | X-RAY CONTRAST AGENTS | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-02-10 | — | — | US | claimed |